Home › Cirrhosis › New York
Cirrhosis clinical trials in New York
6 studies for Cirrhosis are looking for participants at sites in New York.
Cities in New York
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
- Columbia University Medical Center, New York
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 30, 2026 · NCT07325526Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
- New York Presbyterian/Weill Cornell, New York
- Columbia University Iriving School of Medicine, New York
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT05832229National Liver Cancer Screening Trial
- The Feinstein Institutes, Northwell Health, Inc., Manhasset
RecruitingPhase 4
Ages 18 to 85 · All sexes · Updated Sep 25, 2026 · NCT06084234LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn
- Basil Clinical, Laurelton
- Icahn School of Medicine at Mount Sinai, New York
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT06632444A Study of SIPLIZUMAB in AILD and LT Patients
- Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 24, 2025 · NCT06455280Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- Weill Cornell Medicine, New York
- Icahn School of Medicine at Mount Sinai, New York
- Montefiore Medical Center, New York
RecruitingObservational study
Ages 18 to 80 · All sexes · Updated Oct 20, 2025 · NCT04613921From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.